Telmisartan is More Effective in Reducing Systolic Blood Pressure Than Losartan

Main Article Content

Maryeum Islam
Sabiha Y Moni
A Razzaque
Murshid U Rahman
KMR Hassan
Sabrina Razzaque

Abstract

Background: Systemic arterial hypertension is the leading cause of mortality and morbidity worldwide and among the antihypertensive drugs, Telmisartan and Losartan are the more commonly used anti-hypertensive drugs. Methods: This quasi-experimental study was conducted on 90 patients of mild to moderate hypertensive patients at the department of Pharmacology in collaboration with the Department of Medicine, Rajshahi Medical College and hospital, Rajshahi. Data were collected by a semi structured questionnaire and analysis were done by SPSS version-24. Results: Telmisartan is more effective in reducing systolic blood pressure than Losartan and it was statistically significant (p < 0.001). Telmisartan also reduced diastolic blood pressure more effectively than Losartan but it was statistically non-significant (p > 0.05). Conclusion: The study concluded that both Telmisartan and Losartan were found effective in reducing blood pressure but Telmisartan was more effective than Losartan.

Article Details

How to Cite
1.
Islam M, Moni SY, A Razzaque, Rahman MU, KMR Hassan, Razzaque S. Telmisartan is More Effective in Reducing Systolic Blood Pressure Than Losartan. TAJ. 2024;37(1):126-131. doi:10.70818/taj.v37i1.0199
Section
Articles

How to Cite

1.
Islam M, Moni SY, A Razzaque, Rahman MU, KMR Hassan, Razzaque S. Telmisartan is More Effective in Reducing Systolic Blood Pressure Than Losartan. TAJ. 2024;37(1):126-131. doi:10.70818/taj.v37i1.0199

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.